The global hemodialysis and peritoneal dialysis market continues to witness significant growth, offering life-saving treatment options for patients with kidney diseases. Hemodialysis and peritoneal dialysis therapies have become crucial in managing chronic kidney disease and end-stage renal failure, enhancing patients' quality of life. Technological advancements in dialysis equipment and increasing healthcare infrastructure across the globe further support the market's expansion. With a focus on improving patient outcomes and accessibility to dialysis treatments, the market is poised for a promising future.
Access Full Report: https://www.databridgemarketresearch.com/reports/global-hemodialysis-peritoneal-dialysis-market
Data Bridge Market Research analyses that the Global Hemodialysis and Peritoneal Dialysis Market is expected to grow at a CAGR of 6.55% in the forecast period of 2022 to 2029. The increasing prevalence of chronic kidney disease (CKD) and end-stage renal disease (ESRD) is driving the demand for dialysis therapies, such as hemodialysis and peritoneal dialysis. These treatments are essential for managing and sustaining the health of patients with advanced kidney conditions, providing life-saving support, and improving their overall quality of life.
Key Findings of the Study
The increasing prevalence of cardiovascular diseases is expected to drive the market's growth rate
The increasing prevalence of cardiovascular diseases, such as hypertension and diabetes, is closely linked to kidney health and kidney-related disorders such as chronic kidney disease (CKD). As cardiovascular diseases progress, they can cause damage to the kidneys and lead to end-stage renal disease (ESRD), requiring dialysis treatments. The rising incidence of cardiovascular diseases drives the growing demand for dialysis services as a crucial therapeutic intervention to manage kidney-related complications and improve patient outcomes.
Report Scope and Market Segmentation
Report Metric
|
Details
|
Forecast Period
|
2022 to 2029
|
Base Year
|
2021
|
Historic Years
|
2020 (Customizable to 2014-2019)
|
Segments Covered
|
Hemodialysis Products (Hemodialysis Machines, Center-Use Hemodialysis Machines, Home-Use Hemodialysis Machines, Hemodialysis Consumables and Supplies), Dialyzers Material Type (Synthetic Dialyzers, Cellulose-Based Dialyzers), Flux Type (High-Flux, Dialyzers, low Flux Dialyzers, Bloodlines Sets and tubes, Hemodialaysis Concentrates/Dialysates, Alkaline Concentrates, Acidic Concentrates, Hemodialysis Access Products, AV Fistula Needles, Arteriovenous Grafts, Central Venous Catheters, Other Hemodialysis Consumables), Hemodialysis Modality (Conventional Hemodialysis, Short Daily Hemodialysis, Nocturnal Hemodialysis (NHD)), Hemodialysis Water Treatment Systems (Central Water Disinfection Systems, Portable Water Disinfection Systems), Peritoneal Dialysis Products and Services (Peritoneal Dialysis Concentrates/Dialysates, Peritoneal Dialysis Machines, Peritoneal Dialysis Catheters, Peritoneal Dialysis Transfer Sets, Other products, Peritoneal Dialysis Services), Peritoneal Dialysis Modality (Continuous Ambulatory Peritoneal Dialysis (CAPD), Ambulatory Peritoneal Dialysis (APD)), Disease Indication (Acute Kidney Infections, ESRD, Septic Shock, Multi-Organ Failure, Others), Usage (In-Center Dialysis, Hospital Dialysis, Independent Dialysis, Home Dialysis, Peritoneal Dialysis, Home Hemodialysis (HHD)), End User (Hospitals, Dialysis Centers, Home Care Settings)
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
Market Players Covered
|
DaVita Inc. (U.S.), Baxter (U.S.), B. Braun Melsungen AG (Germany), Diaverum (Sweden), Nipro (Japan), NxStage Medical, Inc. (U.S.), Nikkiso Co., Ltd. (Japan), Mar Cor Purification (U.S.), Asahi Kasei Medical Co., Ltd. (Japan), Rockwell Medical (U.S.), Medtronic (Ireland), Dialifegroup (Italy), JMS Co. Ltd. (Japan), Atlantic Biomedical (Ireland), 3M (U.S.), Allmed Medical Care Holdings Limited (Hong Kong), Isopure Corp. (U.S.), and C. R. Bard, Inc. (now part of Becton Dickinson) (U.S.), among others.
|
Data Points Covered in the Report
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Segment Analysis:
血液透析和腹膜透析市場根據血液透析產品、透析器材料類型、通量類型、血液透析方式、血液透析水處理系統、腹膜透析產品和服務、腹膜透析方式、疾病適應症、用途和最終用戶進行細分
- 根據血液透析產品，血液透析和腹膜透析市場細分為血液透析機、中心用血液透析機、家用血液透析機以及血液透析耗材和用品。
- 根據透析器材料類型，血液透析和腹膜透析市場分為合成透析器和纖維素基透析器。
- 根據通量類型，血液透析和腹膜透析市場細分為高通量透析器、低通量透析器、血統套件和管、血液透析濃縮液/透析液、鹼性濃縮液、酸性濃縮液、血液透析通路產品、動靜脈瘻管、動靜脈移植物、中心靜脈導管和其他血液透析耗材。
- 根據血液透析方式，血液透析和腹膜透析市場分為常規血液透析、短期每日血液透析和夜間血液透析 (nhd)。
- 根據血液透析水處理系統，血液透析和腹膜透析市場細分為中央水消毒系統和攜帶式水消毒系統。
- 根據腹膜透析產品和服務，血液透析和腹膜透析市場細分為腹膜透析濃縮液/透析液、腹膜透析機、腹膜透析導管、腹膜透析轉移套件、其他產品和腹膜透析服務。
- 根據腹膜透析方式，血液透析和腹膜透析市場分為持續性不臥床腹膜透析 (CAPD) 和不臥床腹膜透析 (APD)。
- 根據疾病適應症，血液透析和腹膜透析市場分為急性腎臟感染、ESRD、感染性休克、多重器官衰竭等。
- 根據用途，血液透析和腹膜透析市場分為中心透析、醫院透析、獨立透析、家庭透析、腹膜透析和家庭血液透析 (HHD)。
- 根據最終用戶，血液透析和腹膜透析市場分為醫院、透析中心和家庭護理環境。
主要參與者
Data Bridge Market Research 認為以下公司是血液透析和腹膜透析 市場的主要參與者，它們是 NxStage Medical, Inc.（美國）、Nikkiso Co., Ltd.（日本）、Mar Cor Purification（美國）、Asahi Kasei Medical Co., Ltd.（日本）、Rockwell Medical（美國）、Medtronic（愛爾蘭）、DiaCmed（愛爾蘭）、AJ.S.
市場發展
- 2021 年，Mar Cor（Cantel Medical Corporation）宣布推出其創新的 EON 便攜式血液透析水系統
- 2020年，費森尤斯醫療保健股份公司宣布推出不含PVC的腹膜透析液袋，專為居家透析治療而設計。
- 2020 年，百特國際公司 (Baxter International Inc.) 獲得 FDA 批准 Theranova 透析器的 De Novo 申請，該透析器旨在提供擴展血液透析 (HDx) 療法。
區域分析
從地理上看，血液透析和腹膜透析市場報告涵蓋的國家包括北美洲的美國、加拿大和墨西哥、歐洲的德國、法國、英國、荷蘭、瑞士、比利時、俄羅斯、義大利、西班牙、土耳其、歐洲其他地區、中國、日本、印度、韓國、新加坡、馬來西亞、澳洲、泰國、印尼、菲律賓、亞太地區 (APAC) 的其他地區、美國地區的其他地區、美國地區的歐洲地區、歐洲地區 (AME)。
根據 Data Bridge 市場研究分析：
2022 年至 2029 年預測期內，北美是血液透析和腹膜透析市場的主導地區
北美在血液透析和腹膜透析市場的主導地位可以歸因於其廣泛的透析中心網絡，為腎臟疾病患者提供廣泛的治療機會。此外，該地區不斷引進新的和先進的透析產品和技術，進一步提高了患者的照護和治療效果。這些因素的結合使北美成為血液透析和腹膜透析的領先市場，滿足了民眾日益增長的醫療保健需求。
預計2022 年至 2029 年預測期內，亞太地區將成為血液透析和腹膜透析市場成長最快的地區
亞太地區血液透析和腹膜透析市場的顯著增長是由該地區龐大的目標人群推動的，其中包括大量患有腎臟相關疾病的患者，例如慢性腎病 (CKD) 和終末期腎病 (ESRD)。隨著亞太地區人口老化和風險因素的流行，對透析治療的需求不斷上升，使其成為預測期內血液透析和腹膜透析服務的有前景的市場。
有關血液透析和腹膜透析市場 報告的更多詳細信息，請點擊此處 - https://www.databridgemarketresearch.com/reports/global-hemodialysis-peritoneal-dialysis-market
